Orthogon Therapeutics: Funding, Investors & Team (Oct 2026)
Orthogon Therapeutics is a pre-clinical stage, drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets.
Orthogon Therapeutics has raised $24.2M across 3 funding rounds on record, the most recent an undisclosed round of $11.0M announced in Apr 2026.
That round is above the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.
Orthogon Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Orthogon Therapeutics Funding Rounds
Orthogon Therapeutics raised $8.0M in a Series B announced in Nov 2021.
3.1 years later, an undisclosed round of $5.2M was announced in Dec 2024.
1.3 years later, an undisclosed round of $11.0M was announced in Apr 2026.
Orthogon Therapeutics Founders and Leadership Team
Contact details for the Orthogon Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Orthogon Therapeutics Funding Compared to Other Health Care Startups
Orthogon Therapeutics' latest round of $11.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Orthogon Therapeutics in Health Care and Canton
Companies Similar to Orthogon Therapeutics
Treso operates as a financial software provider that develops an integrated financial operating system…
Optain produces medical tools and technology with the aim of providing healthcare access to everyone,…
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Orthogon Therapeutics Funding FAQs
What does Orthogon Therapeutics do?
Orthogon Therapeutics is a pre-clinical stage, drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets.
How much funding has Orthogon Therapeutics raised?
Orthogon Therapeutics has raised $24.2M across 3 rounds on record. The most recent is an undisclosed round of $11.0M announced in Apr 2026.
When did Orthogon Therapeutics last raise funding?
Orthogon Therapeutics' most recent funding round on record is an undisclosed round of $11.0M, announced in Apr 2026.
Who founded Orthogon Therapeutics?
FundedIQ lists Ali Munawar (Founder), Mordechay Ilovich (Founder) at Orthogon Therapeutics.
Where is Orthogon Therapeutics headquartered?
Orthogon Therapeutics is based in Canton, Massachusetts, United States.
How many employees does Orthogon Therapeutics have?
Orthogon Therapeutics is in the 1-10 employee band.
How does Orthogon Therapeutics' funding compare to other Health Care startups?
Orthogon Therapeutics' latest round of $11.0M is above the $5.0M median round size for Health Care companies on FundedIQ across 3,660 tracked companies over the last two years.
About FundedIQ's Orthogon Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orthogon Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.